Every drug has its risks, no matter how tremendous its benefits may be, and sometimes it can take a while to uncover less obvious side effects. New research suggests that GLP-1 medications like semaglutide—the active ingredient in popular drugs Ozempic and Wegovy—might leave some users feeling a little wheezy.

Researchers at the University of Southern California and others examined the medical records of people taking GLP-1s for their type 2 diabetes. Compared to people on other diabetes treatments, GLP-1 users were more likely to develop a chronic cough, they found. The findings warrant more study into this potential side effect and why it may be happening, the researchers say.

A potential risk of chronic cough?

The most common side effects of GLP-1s are gastrointestinal, such as nause

See Full Page